Sphs stock zacks

Equities research analysts expect Sophiris Bio Inc (NASDAQ:SPHS) to announce earnings of ($0.07) per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Sophiris Bio’s earnings. The lowest EPS estimate is ($0.09) and the highest is ($0.04). Sophiris Bio reported earnings of ($0.10) per share during the same quarter last […] Zacks Small-Cap Research David Bautz, PhD May 14, 2019 …

SPHS Sophiris Bio, Inc. Stock Quote - Stock Screener Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of products for the treatment of urological diseases. Zacks Small Cap Research - SPHS: Awaiting Feedback from ... Please visit our website for additional information on Zacks SCR. DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a … Zacks Small Cap Research - SPHS: Single Phase 3 Clinical ... Please visit our website for additional information on Zacks SCR. DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a …

Equities research analysts expect Sophiris Bio Inc (NASDAQ:SPHS) to announce earnings of ($0.07) per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Sophiris Bio’s earnings. The lowest EPS estimate is ($0.09) and the highest is ($0.04). Sophiris Bio reported earnings of ($0.10) per share during the same quarter last […]

Please visit our website for additional information on Zacks SCR. DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a … Invesco S&P 500 High Dividend L (SPHD) Stock Price, Quote ... Find the latest Invesco S&P 500 High Dividend L (SPHD) stock quote, history, news and other vital information to help you with your stock trading and investing. Zacks Small Cap Research - SPHS: EMA Guidance on Phase 3 ... By David Bautz, PhD NASDAQ:SPHS READ THE FULL SPHS RESEARCH REPORT Business Update Sophiris Bio Inc. (NASDAQ:SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign prostatic hyperplasia (BPH). The company’s lead candidate, topsalysin (PRX302), is a genetically engineered SOPHIRIS BIO INC (SPHS) Interactive Stock Chart - Yahoo ...

Get the latest SOPHIRIS BIO INC (SPHS) stock news and headlines to help you in your trading and investing decisions. Zacks Small Cap Research SPHS READ THE FULL SPHS RESEARCH REPORT

Zacks Small-Cap Research David Bautz, PhD May 14, 2019 … Zacks Small-Cap Research David Bautz, PhD 312 dbautz@zacks.com scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 May 14, 2019 -265 9471 SPHS: EMA Guidance on Phase 3 Clinical Trial for Topsalysin Expected in 2Q19… Based on our probability adjusted DCF model that takes into account potential future revenues from

Stock quote for Sophiris Bio Inc. Common Stock (SPHS) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq.

Jun 20, 2019 · Sophiris Bio Inc. (SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign … SPHS: Topline Results from Phase 2b Study of Topsalysin at ... Mar 26, 2018 · Sophiris Bio Inc. (SPHS) is developing treatments for localized clinically significant prostate cancer and lower urinary tract symptoms of benign … FreddyGee (@HFHInc) | Stocktwits

Zacks Small-Cap Research November 18, 2019 David Bautz ...

Zacks Small Cap Research - SPHS: Single Phase 3 Clinical ... Please visit our website for additional information on Zacks SCR. DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a … Invesco S&P 500 High Dividend L (SPHD) Stock Price, Quote ... Find the latest Invesco S&P 500 High Dividend L (SPHD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Sophiris Bio Inc. (SPHS) Stock Message Board - InvestorsHub Sophiris Bio Inc. Sophiris Bio Inc. is a Canadian urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia (BPH or enlarged prostate), a large unsatisfied market. Zacks Small-Cap Research David Bautz, PhD August 27, 2019 ...